EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High Performance of a Dominant/X-Linked Gene Panel in Patients with Neurodevelopmental Disorders

Nino Spataro iD, Juan Pablo Trujillo-Quintero, Carmen Manso, Elisabeth Gabau, Nuria Capdevila iD, Victor Martinez-Glez iD, Antoni Berenguer-Llergo iD, Sara Reyes, Anna Brunet, Neus Baena, Miriam Guitart, Anna Ruiz iD

Genes · 2023

DOI: 10.3390/genes14030708 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2023. Verfasst von Nino Spataro und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genomic Medicine, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de B…. Hauptthemen laut MEDLINE: Neurodevelopmental Disorders, Intellectual Disability, Autistic Disorder. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut d’investigació i Innovació Parc Taulí I3PT, CERCA Programme/Generalitat de Catalunya, Instituto de Salud Carlos III-FEDER.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodevelopmental disorders (NDDs) affect 2–5% of the population and approximately 50% of cases are due to genetic factors. Since de novo pathogenic variants account for the majority of cases, a gene panel including 460 dominant and X-linked genes was designed and applied to 398 patients affected by intellectual disability (ID)/global developmental delay (GDD) and/or autism (ASD). Pathogenic variants were identified in 83 different genes showing the high genetic heterogeneity of NDDs. A molecular diagnosis was established in 28.6% of patients after high-depth sequencing and stringent variant filtering. Compared to other available gene panel solutions for NDD molecular diagnosis, our panel has a higher diagnostic yield for both ID/GDD and ASD. As reported previously, a significantly higher diagnostic yield was observed: (i) in patients affected by ID/GDD compared to those affected only by ASD, and (ii) in females despite the higher proportion of males among our patients. No differences in diagnostic rates were found between patients affected by different levels of ID severity. Interestingly, patients harboring pathogenic variants presented different phenotypic features, suggesting that deep phenotypic profiling may help in predicting the presence of a pathogenic variant. Despite the high performance of our panel, whole exome-sequencing (WES) approaches may represent a more robust solution. For this reason, we propose the list of genes included in our customized gene panel and the variant filtering procedure presented here as a first-tier approach for the molecular diagnosis of NDDs in WES studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodevelopmental DisordersIntellectual DisabilityAutistic DisorderMaleFemaleHumansGenes, X-LinkedGenetic Testing

Stichwörter der Autor:innen

autismgene panelintellectual disabilityneurodevelopmental disordersnext generation sequencingre-analysis

Autor:innen und Institutionen

  • Center for Genomic Medicine, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, 08208 Sabadell, Spain.
  • Genetics Unit, Laboratory Service, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, 08208 Sabadell, Spain.
  • Paediatric Unit, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, 08208 Sabadell, Spain.
  • Rheumatology Department, Biostatistics and Bioinformatics at Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, 08208 Sabadell, Spain.

ORCID-Profile: Nino Spataro, Nuria Capdevila, Victor Martinez-Glez, Antoni Berenguer-Llergo, Anna Ruiz

Förderung

  • Institut d’investigació i Innovació Parc Taulí I3PT
  • CERCA Programme/Generalitat de Catalunya
  • Instituto de Salud Carlos III-FEDER

Zitieren

APA

Spataro, N., Trujillo-Quintero, J. P., Manso, C., Gabau, E., Capdevila, N., Martinez-Glez, V., Berenguer-Llergo, A., Reyes, S., Brunet, A., Baena, N., Guitart, M., & Ruiz, A. (2023). High Performance of a Dominant/X-Linked Gene Panel in Patients with Neurodevelopmental Disorders. Genes. https://doi.org/10.3390/genes14030708

Vancouver

Spataro N, Trujillo-Quintero JP, Manso C, Gabau E, Capdevila N, Martinez-Glez V, et al. High Performance of a Dominant/X-Linked Gene Panel in Patients with Neurodevelopmental Disorders. Genes. 2023. doi:10.3390/genes14030708

BibTeX
@article{Spataro2023,
  author = {Spataro, Nino and Trujillo-Quintero, Juan Pablo and Manso, Carmen and Gabau, Elisabeth and Capdevila, Nuria and Martinez-Glez, Victor and Berenguer-Llergo, Antoni and Reyes, Sara and Brunet, Anna and Baena, Neus and Guitart, Miriam and Ruiz, Anna},
  title = {High Performance of a Dominant/X-Linked Gene Panel in Patients with Neurodevelopmental Disorders},
  journal = {Genes},
  year = {2023},
  doi = {10.3390/genes14030708}
}
Kostenlos starten →